In dermatology and skin care routines, GHK-Cu is often contrasted with retinol and retinoids because it may support skin and hair research with less irritation, although mild redness or irritation can still occur
Legal Status / FDA Liraglutide is FDA-approved and legally available by prescription in the United States under two brand names: Victoza (approved January 2010): Type 2 diabetes in adults and children aged 10+, dosed at 1.2 to 1.8 mg daily Saxenda (approved December 2014): Chronic weight management in adults with BMI of 30 or greater (or 27+ with a weight-related comorbidity) and adolescents aged 12+ with obesity, dosed at 3.0 mg daily Liraglutide is not a controlled substance and is classified as a prescription medication in all major markets

Usage Instructions Inject once weekly under the skin (abdomen, thigh, upper arm) Start at 0.25 mg weekly for 4 weeks, then increase as directed Doses may be raised to 0.5 mg, 1 mg, or 2 mg weekly Use at the same time each week (with or without food) Rotate injection sites to prevent skin irritation Side Effects Nausea, vomiting, diarrhea or constipation Loss of appetite Fatigue or headache Rare: pancreatitis, gallbladder problems, kidney injury, allergic reactions Increased risk of thyroid tumors in animal studies (not seen in humans) Side effects are often mild and improve with time
In particular, adequate intake of both folate and vitamin B 12 is important in maintaining the integrity of the myelin sheath, and thiamin is needed for maintenance of the nerves membrane potential and for proper nerve conductance (3)
It is not known if Foundayo is safe and effective for use in children
2 The MACE end point occurred in 6.5% of participants who received semaglutide vs 8% of those who received placebo